Cat.#: ACPP-1248
| Despition | Mitofusin 2 Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1022 | Recombinant Human Integrin beta 1 Protein (Fc Tag) (AC1022) | 50 µg | inquiry |
| ACPP-1212 | PAX8 Blocking Peptide (AC1212) | 250 µg | inquiry |
| ACPP-1358 | CRMP3 Blocking Peptide (AC1358) | 250 µg | inquiry |
| ACPP-1644 | Human Vimentin Protein (AC1644) | 20 µg | inquiry |
| ACPP-1580 | Mouse LGALS9 Protein (AC1580) | 2 µg | inquiry |
| ACPP-1630 | Human ENO2 Protein, His (AC1630) | 2 µg | inquiry |
| ACPP-1545 | Human YWHAG Protein (AC1545) | 5 µg | inquiry |
| ACPP-1362 | MERTK Blocking Peptide (AC1362) | 250 µg | inquiry |
| ACPP-1654 | Human ATXN3 Protein (AC1654) | 2 µg | inquiry |
| ACPP-1038 | Recombinant Human VCAM1 Protein (6×His Tag) (AC1038) | 50 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.